Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001522780-25-000007
Filing Date
2025-10-10
Accepted
2025-10-10 16:12:24
Documents
1
Period of Report
2025-10-08

Document Format Files

Seq Description Document Type Size
1 form4-10102025_081021.html 4  
1 form4-10102025_081021.xml 4 7321
  Complete submission text file 0001522780-25-000007.txt   8826
Mailing Address C/O STOKE THERAPEUTICS, INC. 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address
Kaye Edward M. MD (Reporting) CIK: 0001522780 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38938 | Film No.: 251388231

Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Issuer) CIK: 0001623526 (see all company filings)

EIN.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)